Market Movers

International Business Machines Corporation’s Stock Price Skyrockets to $258.27, Notching a Robust 12.96% Increase

By January 31, 2025 No Comments

International Business Machines Corporation (IBM)

258.27 USD +29.64 (+12.96%) Volume: 15.32M

International Business Machines Corporation’s stock price soars to 258.27 USD, showcasing a significant trading session increase of +12.96% and a commendable YTD surge of +17.49%, with a robust trading volume of 15.32M, reflecting the strong market confidence in IBM’s performance.


Latest developments on International Business Machines Corporation

International Business Machines (NYSE:IBM) stock price saw a significant surge today after reporting strong earnings driven by AI technology. With shares hitting record highs, analysts revisited price targets and Bank of America set a new target of $270.00. Despite insiders selling $2.6 million in shares, the stock soared 14% on better-than-expected earnings and a positive sales outlook. IBM’s Q4 earnings beat estimates by $0.15 EPS, leading to a 12% surge and impacting top ETFs. The company also announced a quarterly dividend of $1.67 per share, payable on March 10. With AI bookings driving revenue growth and partnerships with companies like Telefónica for quantum cybersecurity, IBM continues to defy naysayers and maintain a bullish outlook.


International Business Machines Corporation on Smartkarma

Analysts on Smartkarma are closely monitoring International Business Machines (IBM) as new insights are published. Tech Supply Chain Tracker reported on a potential tri-fold smartphone launch by TCL chair pending market demand, aiming to disrupt the phone industry. Additionally, Baptista Research highlighted IBM’s focus on hybrid cloud and artificial intelligence, key elements for growth and client engagement strategies. The report also mentioned an independent valuation using Discounted Cash Flow (DCF) methodology to evaluate IBM’s future price.

On the other hand, Caixin Global reported a bearish sentiment as IBM decided to shut down two major research and development units in China due to declining business. This move reflects a broader trend of U.S. tech firms scaling back their presence in the country. The affected units, China Development Lab (CDL) and China Systems Lab (CSL), had significant employee numbers, indicating a strategic shift for IBM in response to market dynamics.


A look at International Business Machines Corporation Smart Scores

FactorScoreMagnitude
Value3
Dividend5
Growth3
Resilience2
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

International Business Machines Corporation (IBM) is expected to have a positive long-term outlook based on the Smartkarma Smart Scores. With a high score in Dividend and moderate scores in Value, Growth, and Momentum, IBM is showing strength in providing returns to its shareholders through dividends. However, the company’s lower score in Resilience indicates some potential risks that investors should be aware of. Overall, IBM’s focus on advanced information technology solutions positions it well for continued growth and success in the international business market.

IBM, also known as International Business Machines Corporation, is a global leader in providing computer solutions and advanced information technology services. With a strong emphasis on dividends and a solid track record in growth and momentum, IBM continues to be a key player in the industry. While the company may face some challenges in terms of resilience, its global sales and distribution network, along with a wide range of products and services, position IBM for long-term success in the international business arena.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars